![Nardin Nakhla](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Théo Risopoulos | M | - |
Simmunome Ai
![]() Simmunome Ai BiotechnologyHealth Technology Simmunome, Inc. is a Canadian company founded in 2017 that uses AI to create disease models based on multi-omic data. The company is based in Montréal, Canada. The company's clinical trial simulations provide insights, allowing for go/no-go decisions and de-risking of pipelines, ultimately reducing R&D costs. | - |
Rhiannon Davis | F | - |
Simmunome Ai
![]() Simmunome Ai BiotechnologyHealth Technology Simmunome, Inc. is a Canadian company founded in 2017 that uses AI to create disease models based on multi-omic data. The company is based in Montréal, Canada. The company's clinical trial simulations provide insights, allowing for go/no-go decisions and de-risking of pipelines, ultimately reducing R&D costs. | - |
Lise Birikundavyi | - | - |
Simmunome Ai
![]() Simmunome Ai BiotechnologyHealth Technology Simmunome, Inc. is a Canadian company founded in 2017 that uses AI to create disease models based on multi-omic data. The company is based in Montréal, Canada. The company's clinical trial simulations provide insights, allowing for go/no-go decisions and de-risking of pipelines, ultimately reducing R&D costs. | - |
Armstrong Murira | M | - |
Simmunome Ai
![]() Simmunome Ai BiotechnologyHealth Technology Simmunome, Inc. is a Canadian company founded in 2017 that uses AI to create disease models based on multi-omic data. The company is based in Montréal, Canada. The company's clinical trial simulations provide insights, allowing for go/no-go decisions and de-risking of pipelines, ultimately reducing R&D costs. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Canada | 4 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Nardin Nakhla
- Contatti personali